Classic view of this page
Multiple pterygium syndrome, lethal type NGS panel
Clinical Genetic Test
Help
offered by
HNL Genomics Connective Tissue Gene Tests
View lab's test page
LinkOut
GTR Test Accession: Help GTR000559240.1
INHERITED DISEASESYNDROMIC DISEASENERVOUS SYSTEM ... View more
Registered in GTR: 2018-01-29
View version history
Last annual review date for the lab: 2023-12-22 LinkOut
At a Glance
Test purpose: Help
Diagnosis; Mutation Confirmation
Conditions (7): Help
Congenital myasthenic syndrome 3A; Autosomal recessive multiple pterygium syndrome; Congenital myasthenic syndrome 3B more...
Genes (3): Help
CHRNA1 (2q31.1); CHRND (2q37.1); CHRNG (2q37.1)
Methods (2): Help
Molecular Genetics - Sequence analysis of the entire coding region: Next-Generation (NGS)/Massively parallel sequencing (MPS); ...
Target population: Help
Individuals whose clinical findings are consistent with the specific disorder.
Clinical validity: Help
Not provided
Clinical utility: Help
Not provided
Ordering Information
Offered by: Help
HNL Genomics Connective Tissue Gene Tests
View lab's website
View lab's test page
Specimen Source: Help
Who can order: Help
  • Genetic Counselor
  • Health Care Provider
  • Licensed Physician
Test Order Code: Help
2274
View other test codes
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Please use the equisition form and easy-to-use submission instructions available on the CTGT web site
Order URL
Test service: Help
Clinical Testing/Confirmation of Mutations Identified Previously
    OrderCode: 2274
Confirmation of research findings
Test additional service: Help
Custom Prenatal Testing
    Comment: Optional Maternal Cell Contamination (MCC) testing is available for all prenatal tests
Custom mutation-specific/Carrier testing
Test development: Help
Test developed by laboratory but exempt from FDA oversight (eg. NYS CLEP approved, offered within a hospital or clinic)
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Lab contact for this test, Test strategy
Conditions Help
Total conditions: 7
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 3
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 2
Method Category Help
Test method Help
Instrument *
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
Targeted variant analysis
Bi-directional Sanger Sequence Analysis
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis; Mutation Confirmation
Target population: Help
Individuals whose clinical findings are consistent with the specific disorder.
Research:
Is research allowed on the sample after clinical testing is complete? Help
CTGT does not perform research on samples after testing is complete.
Recommended fields not provided:
Clinical validity, Clinical utility, What is the protocol for interpreting a variation as a VUS?, Sample negative report, Sample positive report
Technical Information
Test Confirmation: Help
Positive results are confirmed on a new DNA preparation using repeat sequence analysis.
Availability: Help
Tests performed
Entire test performed in-house

Test performance comments
If applicable, Maternal Cell Contamination testing is performed by an outside CLIA-approved university laboratory.
Analytical Validity: Help
Sensitivity and Specificity >99%
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Intra-Laboratory

PT Provider: Help
Other

Description of PT method: Help
Internal proficiency testing is conducted biannually in compliance with all CAP regulations. Inter-laboratory proficiency testing is performed for some tests.
Recommended fields not provided:
Assay limitations, Description of internal test validation method, Citations for Analytical validity, Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review: Help
Category: Not Applicable
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.